These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 8536297)
1. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Gallai V; Sarchielli P; Floridi A; Franceschini M; Codini M; Glioti G; Trequattrini A; Palumbo R Cephalalgia; 1995 Oct; 15(5):384-90. PubMed ID: 8536297 [TBL] [Abstract][Full Text] [Related]
2. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Sarchielli P; Alberti A; Codini M; Floridi A; Gallai V Cephalalgia; 2000 Dec; 20(10):907-18. PubMed ID: 11304026 [TBL] [Abstract][Full Text] [Related]
3. Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura. Friberg L; Olesen J; Olsen TS; Karle A; Ekman R; Fahrenkrug J Cephalalgia; 1994 Feb; 14(1):47-54. PubMed ID: 7515329 [TBL] [Abstract][Full Text] [Related]
4. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872 [TBL] [Abstract][Full Text] [Related]
5. Plasma levels of vasoactive neuropeptides in pediatric patients with migraine during attack and attack-free periods. Hanci F; Kilinc YB; Kilinc E; Turay S; Dilek M; Kabakus N Cephalalgia; 2021 Feb; 41(2):166-175. PubMed ID: 32903061 [TBL] [Abstract][Full Text] [Related]
6. Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients. Jang MU; Park JW; Kho HS; Chung SC; Chung JW Oral Dis; 2011 Mar; 17(2):187-93. PubMed ID: 20659258 [TBL] [Abstract][Full Text] [Related]
7. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache. Nicolodi M; Del Bianco E Cephalalgia; 1990 Feb; 10(1):39-50. PubMed ID: 1690601 [TBL] [Abstract][Full Text] [Related]
8. Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case-Control and Case-Crossover Settings: A Systematic Review and Meta-Analysis. Frederiksen SD; Bekker-Nielsen Dunbar M; Snoer AH; Deen M; Edvinsson L Headache; 2020 Jun; 60(6):1132-1164. PubMed ID: 32293721 [TBL] [Abstract][Full Text] [Related]
9. Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders. Sarchielli P; Pini LA; Zanchin G; Alberti A; Maggioni F; Rossi C; Floridi A; Calabresi P Cephalalgia; 2006 Mar; 26(3):257-65. PubMed ID: 16472331 [TBL] [Abstract][Full Text] [Related]
10. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Fusayasu E; Kowa H; Takeshima T; Nakaso K; Nakashima K Pain; 2007 Apr; 128(3):209-214. PubMed ID: 17123735 [TBL] [Abstract][Full Text] [Related]
11. [Frequent episodic migraine and calcitonin gene-related peptide. Influence of treatment with topiramate and zonisamide on levels of the peptide]. Garcia-Estevez DA; Pardo-Parrado M; Silvarrey-Rodriguez S Rev Neurol; 2017 Aug; 65(4):153-156. PubMed ID: 28726232 [TBL] [Abstract][Full Text] [Related]
12. Neuropeptides as a Marker for Chronic Headache. Riesco N; Cernuda-Morollón E; Pascual J Curr Pain Headache Rep; 2017 Apr; 21(4):18. PubMed ID: 28281109 [TBL] [Abstract][Full Text] [Related]
13. Salivary and serum levels of substance P, neurokinin A and calcitonin gene related peptide in burning mouth syndrome. Boras VV; Savage NW; Brailo V; Lukac J; Lukac M; Alajbeg IZ Med Oral Patol Oral Cir Bucal; 2010 May; 15(3):e427-31. PubMed ID: 20038912 [TBL] [Abstract][Full Text] [Related]
14. Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine. Ramón C; Cernuda-Morollón E; Pascual J Curr Opin Neurol; 2017 Jun; 30(3):281-286. PubMed ID: 28234796 [TBL] [Abstract][Full Text] [Related]
15. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine. Cernuda-Morollón E; Martínez-Camblor P; Ramón C; Larrosa D; Serrano-Pertierra E; Pascual J Headache; 2014 Jun; 54(6):987-95. PubMed ID: 24673487 [TBL] [Abstract][Full Text] [Related]
16. Co-variation of neuropeptide Y, calcitonin gene-related peptide, substance P and neurokinin A in joint fluid from patients with temporomandibular joint arthritis. Alstergren P; Appelgren A; Appelgren B; Kopp S; Lundeberg T; Theodorsson E Arch Oral Biol; 1995 Feb; 40(2):127-35. PubMed ID: 7540832 [TBL] [Abstract][Full Text] [Related]
17. Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks. Ashina M; Bendtsen L; Jensen R; Schifter S; Olesen J Pain; 2000 May; 86(1-2):133-8. PubMed ID: 10779670 [TBL] [Abstract][Full Text] [Related]
18. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Goadsby PJ; Edvinsson L; Ekman R Ann Neurol; 1990 Aug; 28(2):183-7. PubMed ID: 1699472 [TBL] [Abstract][Full Text] [Related]
19. Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal. Lee MJ; Lee SY; Cho S; Kang ES; Chung CS J Headache Pain; 2018 Jul; 19(1):53. PubMed ID: 30006780 [TBL] [Abstract][Full Text] [Related]
20. L-arginine/nitric oxide pathway activation in platelets of migraine patients with and without aura. Gallai V; Floridi A; Mazzotta G; Codini M; Tognoloni M; Vulcano MR; Sartori M; Russo S; Alberti A; Michele F; Sarchielli P Acta Neurol Scand; 1996 Aug; 94(2):151-60. PubMed ID: 8891062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]